ROIV logo

Roivant Sciences Ltd. (ROIV) Cash From Operations

Annual CFO:

-$839.45M-$74.18M(-9.69%)
March 31, 2025

Summary

  • As of today, ROIV annual cash from operations is -$839.45 million, with the most recent change of -$74.18 million (-9.69%) on March 31, 2025.
  • During the last 3 years, ROIV annual cash from operations has fallen by -$161.72 million (-23.86%).
  • ROIV annual cash from operations is now -51.96% below its all-time high of -$552.42 million, reached on March 31, 2021.

Performance

1-Year Change

-9.69%

3-Year Change

-23.86%

5-Year Change

-10.19%

15-Year Change

+18.04%

ROIV Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

0.17%
ROIV annual cash from operations is higher than 0.17% of companies in Healthcare sector

Range

All-Time High

-$552.42M
ROIV annual cash from operations is currently -51.96% below its historical high of -$552.42 million

3-Year Low

-$843.39M
ROIV annual cash from operations is currently +0.47% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Mar 31, 2025
ROIV previous annual earnings announcement was published on Mar 31, 2025

Next Annual Earnings Report Date

N/A
ROIV next annual earnings announcement has not yet been scheduled

OtherROIVcash flow metrics

Annual CFI

-$1.77B
ROIV annual cash from investing is -$1.77 billion

Annual CFF

-$1.22B
ROIV annual cash from financing is -$1.22 billion

Annual FCF

-$844.05M
ROIV annual free cash flow is -$844.05 million

Annual CAPEX

$4.60M
ROIV annual capital expenditures is $4.60 million

Quarterly CFO:

-$185.66M+$18.72M(+9.16%)
September 30, 2025

Summary

  • As of today, ROIV quarterly cash from operations is -$185.66 million, with the most recent change of +$18.72 million (+9.16%) on September 30, 2025.
  • Over the past year, ROIV quarterly cash from operations has increased by +$81.14 million (+30.41%).
  • ROIV quarterly cash from operations is now -75.04% below its all-time high of -$106.07 million, reached on March 31, 2021.

Performance

3-Month Change

+9.16%

1-Year Change

+30.41%

3-Year Change

+2.09%

5-Year Change

-75.04%

ROIV Quarterly Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

0.45%
ROIV quarterly cash from operations is higher than 0.45% of companies in Healthcare sector

Range

All-Time High

-$106.07M
ROIV quarterly cash from operations is currently -75.04% below its historical high of -$106.07 million

3-Year Low

-$266.81M
ROIV quarterly cash from operations is currently +30.41% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ROIV previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 9, 2026
ROIV next earnings announcement is scheduled for Feb 9, 2026

OtherROIVcash flow metrics

Quarterly CFI

$120.42M
ROIV quarterly cash from investing is $120.42 million

Quarterly CFF

$62.59M
ROIV quarterly cash from financing is $62.59 million

Quarterly FCF

-$193.51M
ROIV quarterly free cash flow is -$193.51 million

Quarterly CAPEX

$7.85M
ROIV quarterly capital expenditures is $7.85 million

TTM CFO:

-$769.86M+$81.14M(+9.53%)
September 30, 2025

Summary

  • As of today, ROIV TTM cash from operations is -$769.86 million, with the most recent change of +$81.14 million (+9.53%) on September 30, 2025.
  • Over the past year, ROIV TTM cash from operations has increased by +$8.68 million (+1.12%).
  • ROIV TTM cash from operations is now -625.83% below its all-time high of -$106.07 million, reached on March 31, 2021.

Performance

3-Month Change

+9.53%

1-Year Change

+1.12%

3-Year Change

+10.24%

5-Year Change

-625.83%

ROIV TTM Cash From Operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

0.27%
ROIV TTM cash from operations is higher than 0.27% of companies in Healthcare sector

Range

All-Time High

-$106.07M
ROIV TTM cash from operations is currently -625.83% below its historical high of -$106.07 million

3-Year Low

-$857.67M
ROIV TTM cash from operations is currently +10.24% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ROIV previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 9, 2026
ROIV next earnings announcement is scheduled for Feb 9, 2026

OtherROIVcash flow metrics

TTM CFI

$562.97M
ROIV TTM cash from investing is $562.97 million

TTM CFF

-$575.28M
ROIV TTM cash from financing is -$575.28 million

TTM FCF

-$784.38M
ROIV TTM free cash flow is -$784.38 million

TTM CAPEX

$14.52M
ROIV TTM capital expenditures is $14.52 million

Cash From Operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ROIV Cash From Operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-9.7%+30.4%+1.1%
3Y3 Years-23.9%+2.1%+10.2%
5Y5 Years-10.2%-75.0%-625.8%

ROIV Cash From Operations Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-23.9%+0.5%-71.2%+30.4%-8.7%+10.2%
5Y5-Year-52.0%+0.5%-75.0%+30.9%-625.8%+10.2%
All-TimeAll-Time-52.0%+18.0%-75.0%+30.9%-625.8%+10.2%

ROIV Cash From Operations History

DateAnnualQuarterlyTTM
Sep 2025
-
-$185.66M(+9.2%)
-$769.86M(+9.5%)
Jun 2025
-
-$204.38M(-18.4%)
-$851.00M(-1.4%)
Mar 2025
-$839.45M(-9.7%)
-$172.56M(+16.7%)
-$839.45M(-8.3%)
Dec 2024
-
-$207.25M(+22.3%)
-$775.34M(+0.4%)
Sep 2024
-
-$266.81M(-38.4%)
-$778.54M(-9.9%)
Jun 2024
-
-$192.83M(-77.8%)
-$708.16M(+7.5%)
Mar 2024
-$765.27M(+9.3%)
-$108.46M(+48.5%)
-$765.27M(+8.4%)
Dec 2023
-
-$210.45M(-7.1%)
-$835.90M(+1.4%)
Sep 2023
-
-$196.43M(+21.4%)
-$848.04M(-0.8%)
Jun 2023
-
-$249.93M(-39.6%)
-$841.24M(+0.3%)
DateAnnualQuarterlyTTM
Mar 2023
-$843.39M(-24.4%)
-$179.09M(+19.5%)
-$843.39M(-3.9%)
Dec 2022
-
-$222.59M(-17.4%)
-$811.77M(+5.4%)
Sep 2022
-
-$189.63M(+24.8%)
-$857.67M(-8.8%)
Jun 2022
-
-$252.08M(-70.9%)
-$788.64M(-16.4%)
Mar 2022
-$677.73M(-22.7%)
-$147.47M(+45.1%)
-$677.73M(-6.5%)
Dec 2021
-
-$268.49M(-122.6%)
-$636.33M(-73.0%)
Sep 2021
-
-$120.60M(+14.6%)
-$367.83M(-48.8%)
Jun 2021
-
-$141.17M(-33.1%)
-$247.24M(-133.1%)
Mar 2021
-$552.42M(+27.5%)
-$106.07M
-$106.07M
Mar 2020
-$761.83M(+25.6%)
-
-
Mar 2019
-$1.02B
-
-

FAQ

  • What is Roivant Sciences Ltd. annual cash from operations?
  • What is the all-time high annual cash from operations for Roivant Sciences Ltd.?
  • What is Roivant Sciences Ltd. annual cash from operations year-on-year change?
  • What is Roivant Sciences Ltd. quarterly cash from operations?
  • What is the all-time high quarterly cash from operations for Roivant Sciences Ltd.?
  • What is Roivant Sciences Ltd. quarterly cash from operations year-on-year change?
  • What is Roivant Sciences Ltd. TTM cash from operations?
  • What is the all-time high TTM cash from operations for Roivant Sciences Ltd.?
  • What is Roivant Sciences Ltd. TTM cash from operations year-on-year change?

What is Roivant Sciences Ltd. annual cash from operations?

The current annual cash from operations of ROIV is -$839.45M

What is the all-time high annual cash from operations for Roivant Sciences Ltd.?

Roivant Sciences Ltd. all-time high annual cash from operations is -$552.42M

What is Roivant Sciences Ltd. annual cash from operations year-on-year change?

Over the past year, ROIV annual cash from operations has changed by -$74.18M (-9.69%)

What is Roivant Sciences Ltd. quarterly cash from operations?

The current quarterly cash from operations of ROIV is -$185.66M

What is the all-time high quarterly cash from operations for Roivant Sciences Ltd.?

Roivant Sciences Ltd. all-time high quarterly cash from operations is -$106.07M

What is Roivant Sciences Ltd. quarterly cash from operations year-on-year change?

Over the past year, ROIV quarterly cash from operations has changed by +$81.14M (+30.41%)

What is Roivant Sciences Ltd. TTM cash from operations?

The current TTM cash from operations of ROIV is -$769.86M

What is the all-time high TTM cash from operations for Roivant Sciences Ltd.?

Roivant Sciences Ltd. all-time high TTM cash from operations is -$106.07M

What is Roivant Sciences Ltd. TTM cash from operations year-on-year change?

Over the past year, ROIV TTM cash from operations has changed by +$8.68M (+1.12%)
On this page